Chemed (CHE)
(Delayed Data from NYSE)
$574.13 USD
+1.42 (0.25%)
Updated May 9, 2024 04:00 PM ET
After-Market: $573.83 -0.30 (-0.05%) 6:20 PM ET
4-Sell of 5 4
D Value C Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CHE 574.13 +1.42(0.25%)
Will CHE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
EHC or CHE: Which Is the Better Value Stock Right Now?
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Q1 Earnings Miss Estimates
Here's Why You Should Retain Chemed (CHE) Stock for Now
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Other News for CHE
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...
Validation Institute Announces Finalists for 2024 Health Value Awards
Chemed Corporation (CHE) Q1 2024 Earnings Call Transcript
Chemed Corp Breaks Below 200-Day Moving Average - Notable for CHE